379 related articles for article (PubMed ID: 22120122)
21. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
[TBL] [Abstract][Full Text] [Related]
22. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.
Selman MH; de Jong SE; Soonawala D; Kroon FP; Adegnika AA; Deelder AM; Hokke CH; Yazdanbakhsh M; Wuhrer M
Mol Cell Proteomics; 2012 Apr; 11(4):M111.014563. PubMed ID: 22184099
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry.
Selman MH; McDonnell LA; Palmblad M; Ruhaak LR; Deelder AM; Wuhrer M
Anal Chem; 2010 Feb; 82(3):1073-81. PubMed ID: 20058878
[TBL] [Abstract][Full Text] [Related]
24. High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples.
Reusch D; Haberger M; Selman MH; Bulau P; Deelder AM; Wuhrer M; Engler N
Anal Biochem; 2013 Jan; 432(2):82-9. PubMed ID: 23026777
[TBL] [Abstract][Full Text] [Related]
25. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
Anumula KR
J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
[TBL] [Abstract][Full Text] [Related]
26. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
[TBL] [Abstract][Full Text] [Related]
27. IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age.
Twisselmann N; Bartsch YC; Pagel J; Wieg C; Hartz A; Ehlers M; Härtel C
Front Immunol; 2018; 9():3166. PubMed ID: 30713537
[TBL] [Abstract][Full Text] [Related]
28. Glycine additive facilitates site-specific glycosylation profiling of biopharmaceuticals by ion-pairing hydrophilic interaction chromatography mass spectrometry.
Zhao Y; Raidas S; Mao Y; Li N
Anal Bioanal Chem; 2021 Feb; 413(5):1267-1277. PubMed ID: 33244686
[TBL] [Abstract][Full Text] [Related]
29. Changes in subclass-specific IgG Fc glycosylation associated with the postnatal maturation of the murine immune system.
Barrientos G; Habazin S; Novokmet M; Almousa Y; Lauc G; Conrad ML
Sci Rep; 2020 Sep; 10(1):15243. PubMed ID: 32943699
[TBL] [Abstract][Full Text] [Related]
30. Site-specific N-glycosylation of chicken serum IgG.
Suzuki N; Lee YC
Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
[TBL] [Abstract][Full Text] [Related]
31. Profiling and characterization of sialylated N-glycans by 2D-HPLC (HIAX/PGC) with online orbitrap MS/MS and offline MSn.
Hanneman AJ; Strand J; Huang CT
J Pharm Sci; 2014 Feb; 103(2):400-8. PubMed ID: 24302562
[TBL] [Abstract][Full Text] [Related]
32. Analytical characterization of IgG Fc subclass variants through high-resolution separation combined with multiple LC-MS identification.
He XA; Washburn N; Arevalo E; Robblee JH
Anal Bioanal Chem; 2015 Sep; 407(23):7055-66. PubMed ID: 26231686
[TBL] [Abstract][Full Text] [Related]
33. Fc Glycosylation Characterization of Human Immunoglobulins G Using Immunocapture and LC-MS.
Helali Y; Sharma S; Vandeput M; Welba D; Van Antwerpen P; Marchant A; Delporte C
Methods Mol Biol; 2021; 2271():57-71. PubMed ID: 33907999
[TBL] [Abstract][Full Text] [Related]
34. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
Raju TS
Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
[TBL] [Abstract][Full Text] [Related]
35. Isotype-specific glycosylation analysis of mouse IgG by LC-MS.
Maresch D; Altmann F
Proteomics; 2016 May; 16(9):1321-30. PubMed ID: 26960168
[TBL] [Abstract][Full Text] [Related]
36. Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain.
Raju TS; Scallon B
Biotechnol Prog; 2007; 23(4):964-71. PubMed ID: 17571902
[TBL] [Abstract][Full Text] [Related]
37. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
Hodoniczky J; Zheng YZ; James DC
Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
[TBL] [Abstract][Full Text] [Related]
38. High-Throughput Analysis of IgG Fc Glycopeptides by LC-MS.
Falck D; Jansen BC; de Haan N; Wuhrer M
Methods Mol Biol; 2017; 1503():31-47. PubMed ID: 27743357
[TBL] [Abstract][Full Text] [Related]
39. Linkage-specific sialic acid derivatization for MALDI-TOF-MS profiling of IgG glycopeptides.
de Haan N; Reiding KR; Haberger M; Reusch D; Falck D; Wuhrer M
Anal Chem; 2015 Aug; 87(16):8284-91. PubMed ID: 26191964
[TBL] [Abstract][Full Text] [Related]
40. Towards middle-up analysis of polyclonal antibodies: subclass-specific N-glycosylation profiling of murine immunoglobulin G (IgG) by means of HPLC-MS.
Blöchl C; Regl C; Huber CG; Winter P; Weiss R; Wohlschlager T
Sci Rep; 2020 Oct; 10(1):18080. PubMed ID: 33093535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
